Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV+ Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00966160
What this trial is testing

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
University of Cologne 215
Post-approval studies (Phase 4)UnknownNCT00135460
What this trial is testing

Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Danish HIV Research Group 100
Large-scale testing (Phase 3)Study completedNCT00002315
What this trial is testing

A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems

Who this might be right for
HIV InfectionsChickenpox
Glaxo Wellcome 400
Not applicableStudy completedNCT00002217
What this trial is testing

Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Post-approval studies (Phase 4)Ended earlyNCT01602822
What this trial is testing

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Who this might be right for
HIV
Kenneth H. Mayer, MD 11
Not applicableStudy completedNCT02532673
What this trial is testing

Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

Who this might be right for
HIV/AIDS
Bristol-Myers Squibb 1,200
Not applicableUnknownNCT02057003
What this trial is testing

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Who this might be right for
Hepatitis C, ChronicHuman Immunodeficiency Virus
Valme University Hospital 1,000
Not applicableStudy completedNCT02646605
What this trial is testing

Depression Amongst HIV Positive Patients in Lilongwe

Who this might be right for
HIVAIDS
University of North Carolina, Chapel Hill 206
Not applicableStudy completedNCT00002253
What this trial is testing

Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.

Who this might be right for
DiarrheaHIV Infections
Sandoz
Testing effectiveness (Phase 2)Study completedNCT00002088
What this trial is testing

Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial

Who this might be right for
DiarrheaHIV Infections
Biocodex 100
Early research (Phase 1)Study completedNCT00017823
What this trial is testing

Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients

Who this might be right for
HIV Infections
National Institute of Nursing Research (NINR)
Not applicableStudy completedNCT01375881
What this trial is testing

Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice

Who this might be right for
HIV Infections
Janssen-Cilag S.p.A. 31
Early research (Phase 1)Study completedNCT00002351
What this trial is testing

L-735,524 in HIV-Positive Children and Adolescents

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 12
Testing effectiveness (Phase 2)Study completedNCT05571319
What this trial is testing

A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.

Who this might be right for
Metabolic SyndromeHIV Seropositivity
University of Stellenbosch 30
Not applicableStudy completedNCT00046267
What this trial is testing

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00000922
What this trial is testing

Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,710
Early research (Phase 1)Study completedNCT00006495
What this trial is testing

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableUnknownNCT01437475
What this trial is testing

Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients

Who this might be right for
HIV
Tel-Aviv Sourasky Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00227500
What this trial is testing

Pravastatin for Hyperlipidaemia in HIV.

Who this might be right for
HIV InfectionsLipid MetabolismGlucose Metabolism+3 more
Kirby Institute 40
Next Page